Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.

John Paul VerdereseMaria StepanovaBrian LamAndrei RacilaAndrej KolacevskiDavid AllenErin HodsonBahareh Aslani-AmoliMichael HomeyerSarah StanmyreHelen StevensStephanie GarofaloLinda HenryChapy VenkatesanLynn H GerberSteve MotewJ Stephen JonesZobair M Younossi

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

NmAb treatment reduced hospital utilization especially when received within a few days of symptom onset. Further study is needed to validate these findings.

Keyphrases

monoclonal antibody
coronavirus disease
sars cov
healthcare
emergency department
high intensity
combination therapy
zika virus
smoking cessation
respiratory syndrome coronavirus